ChatGPT's Study Mode is only as good as the prompts you give it.

As substance use continues to be a major public health concern among adolescents, researchers from the University of California San Diego analyzed the latest data from one of the nation's largest ...

BEST Base Locations in Palworld 1.0 (Early, Mid & Endgame) | Moxsy Guide Looking for the best place to build your base in Palworld 1.0? In this guide, we'll show you the best base locations for every ...

A new study suggests that apoB, a blood test that measures harmful cholesterol particles, is better than standard LDL cholesterol testing for deciding who needs more intensive treatment. Researchers ...

We might earn a commission if you make a purchase through one of the links. The McClatchy Commerce Content team, which is independent from our newsroom, oversees this content. This article has ...

Every product on this page was chosen by a Harper's BAZAAR editor. We may earn commission on some of the items you choose to buy. Whether your long lengths are overdue for a refresh or you're simply ...

Almost one in four white-collar workers is experiencing a hidden professional crisis: a "mid-career stall," defined as at least five years without a promotion or meaningful raise, new research shows.

MS NOW said it would launch its new programming schedule in mid-June, with most of its new hours starting Monday, June 15. The large series of programming changes will put some familiar faces in new ...

Twenty-three INDY NXT by Firestone drivers took advantage of the six-week break in the schedule before the Month of May at Indianapolis for a series group test April 14-15 at Mid-Ohio Sports Car ...

April 13 (Reuters) - Allogene Therapeutics (ALLO.O), opens new tab said on Monday that interim data from a mid-stage study showed its experimental off-the-shelf CAR-T therapy reduced the risk of ...

New qualitative research shows that students who were admitted through test-optional admissions generally don’t feel underqualified to attend their institutions, despite claims otherwise from those ...

April 7 (Reuters) - Insmed (INSM.O), opens new tab said on Tuesday it ‌would discontinue the development of its treatment for a chronic, inflammatory skin condition, after the drug failed a mid-stage ...